ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg
Siegburg, Germany
Oncologist in Siegburg, North Rhine-Westphalia
Humperdinckstraße 10-14, 53721 Siegburg
About ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Heidelberg Medical Center
2
University of Jena
1
University of Ulm
1
Clinical Trials at ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg
During the past decade, ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage
2009-12-01
2016-12-14
Completed
103
TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study
2012-08-24
2022-05-31
Completed
717
A Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma
2015-06-01
2021-06-24
Completed
564
Trial on the Effect of Isatuximab to Lenalidomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7)
2018-10-18
2025-12-01
Active, not recruiting
662
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg
According to Clinical.Site data, the most researched conditions in "ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg" are
"Multiple Myeloma" (2 trials), "Chronic Myeloid Leukemia" (1 trials) and "Myeloproliferative Neoplasms" (1 trials). Many other conditions were trialed in "ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg" in a lesser frequency.
Clinical Trials Intervention Types at ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg
Most popular intervention types in "ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib" (2 trials), "Dexamethasone" (2 trials), "Lenalidomide" (2 trials), "Isatuximab" (1 trials) and "Nilotinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg
The vast majority of trials in "ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg" are
4 trials for "All" genders.
Clinical Trials Status at ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg
Currently, there are NaN active trials in "ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg
ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg has several departments that took part in Clinical trials: "MarienHospital Onkologische Praxis" - 2 trials
Departments List
Name
City
Trials